Dosing Interval tx [Regulatives / Guidelines]

posted by NPavan – India, 2009-07-27 15:17 (6180 d 13:14 ago) – Posting: # 3987
Views: 3,345

Dear all,

We are going to conduct a study with the combination of drug products for the submission of Canada. As per the Canada Guidelings (Report C Combination drug products) the following parameters must be reported.

1. The ratios of the concentrations of each drug and/or metabolites at the tmax as determined for each drug.
2. The ratios of the concentrations of the drugs at the last time point of the most commonly used dosing interval (i.e., at tx);
3. The ratios of the AUCtx of the drugs and/or metabolites.

Now my doubts are
1. How to calculate the ratios of the concentrations at tx?
2. What is meant by tx?
3. How to calculate the ratios of the AUCtx for test and reference products?

Kindly, clarify my doubts.

Thanks in advance.

--
Eidit: Category changed. [Helmut]

Regards,
Pavan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
359 visitors (0 registered, 359 guests [including 29 identified bots]).
Forum time: 04:32 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5